Rowena A. Bull

6.7k total citations · 1 hit paper
96 papers, 4.1k citations indexed

About

Rowena A. Bull is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rowena A. Bull has authored 96 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hepatology, 37 papers in Infectious Diseases and 36 papers in Epidemiology. Recurrent topics in Rowena A. Bull's work include Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (27 papers) and Animal Virus Infections Studies (18 papers). Rowena A. Bull is often cited by papers focused on Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (27 papers) and Animal Virus Infections Studies (18 papers). Rowena A. Bull collaborates with scholars based in Australia, Canada and United States. Rowena A. Bull's co-authors include Peter A. White, William D. Rawlinson, Andrew R. Lloyd, Fabio Luciani, Mark M. Tanaka, John‐Sebastian Eden, Elise Tu, Nicodemus Tedla, Christopher J. McIver and Lok Bahadur Shrestha and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Rowena A. Bull

91 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

2022 290 citations Lok Bahadur Shrestha, Charles S. P. Foster et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rowena A. Bull Australia	32	2.4k	999	982	885	878	96	4.1k
Shuetsu Fukushi Japan	39	5.1k 2.1×	572 0.6×	1.6k 1.7×	1.4k 1.6×	1.1k 1.2×	132	6.5k
Jason M. Mackenzie Australia	42	3.8k 1.6×	426 0.4×	872 0.9×	848 1.0×	935 1.1×	95	6.5k
Philippe de Micco France	36	1.8k 0.7×	413 0.4×	729 0.7×	250 0.3×	665 0.8×	101	3.5k
Youchun Wang China	34	4.5k 1.8×	1.9k 1.9×	477 0.5×	236 0.3×	878 1.0×	227	6.0k
Alexander N. Lukashev Russia	33	2.4k 1.0×	269 0.3×	484 0.5×	1.5k 1.7×	807 0.9×	122	4.0k
Roland Zell Germany	44	2.1k 0.9×	268 0.3×	866 0.9×	2.2k 2.5×	2.0k 2.3×	150	5.5k
Julie K. Pfeiffer United States	26	1.5k 0.6×	220 0.2×	328 0.3×	602 0.7×	677 0.8×	52	2.9k
Ella Mendelson Israel	45	3.6k 1.5×	293 0.3×	377 0.4×	913 1.0×	2.0k 2.3×	261	6.3k
Mauro Pistello Italy	44	1.7k 0.7×	489 0.5×	1.7k 1.7×	693 0.8×	2.4k 2.7×	233	6.0k
Susana López Mexico	48	4.6k 1.9×	297 0.3×	2.1k 2.2×	1.6k 1.9×	1.0k 1.1×	176	6.1k

Countries citing papers authored by Rowena A. Bull

Since Specialization

Citations

This map shows the geographic impact of Rowena A. Bull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowena A. Bull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowena A. Bull more than expected).

Fields of papers citing papers by Rowena A. Bull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowena A. Bull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowena A. Bull. The network helps show where Rowena A. Bull may publish in the future.

Co-authorship network of co-authors of Rowena A. Bull

This figure shows the co-authorship network connecting the top 25 collaborators of Rowena A. Bull. A scholar is included among the top collaborators of Rowena A. Bull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowena A. Bull. Rowena A. Bull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phetsouphanh, Chansavath, Zong Hong Zhang, Rowena A. Bull, et al.. (2025). Expanded CD16+CD56+Granzyme B+ NK like CD8+ T cells an off target effect of bruton’s tyrosine kinase inhibitors in Waldenström macroglobulinemia. Scientific Reports. 15(1). 34641–34641.

Adhikari, Anurag, Ha Na Kim, Megan S. Lord, et al.. (2024). Characterization of antibody‐dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes. Journal of Medical Virology. 96(1). e29381–e29381. 2 indexed citations

Bull, Rowena A., et al.. (2023). HCV E1 influences the fitness landscape of E2 and may enhance escape from E2-specific antibodies. Virus Evolution. 9(2). vead068–vead068. 5 indexed citations

Foster, Charles S. P., Rowena A. Bull, Nicodemus Tedla, et al.. (2023). Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak. Viruses. 15(2). 522–522. 5 indexed citations

Baird, Sarah, Caroline L. Ashley, Felix Marsh‐Wakefield, et al.. (2023). A unique cytotoxic CD4 ⁺ T cell‐signature defines critical COVID‐19. Clinical & Translational Immunology. 12(8). e1463–e1463. 2 indexed citations

Valencia, Braulio M., Chathurani Sigera, Thiruni Adikari, et al.. (2023). Genomic Surveillance of Recent Dengue Outbreaks in Colombo, Sri Lanka. Viruses. 15(7). 1408–1408. 8 indexed citations

Liang, T. Jake, John Law, Thomas Pietschmann, et al.. (2023). Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model. Clinical Infectious Diseases. 77(Supplement_3). S257–S261. 4 indexed citations

Leung, Preston, et al.. (2022). Evolution of within-host variants of the hepatitis C virus. Infection Genetics and Evolution. 99. 105242–105242. 2 indexed citations

Cai, Curtis, Jerome Samir, Thiruni Adikari, et al.. (2022). Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-γ response in early phase of viral infection. Nature Communications. 13(1). 7543–7543. 14 indexed citations

10.

Bhattacharjee, Shovon, Rakesh Joshi, Muhammad Yasir, et al.. (2021). Graphene- and Nanoparticle-Embedded Antimicrobial and Biocompatible Cotton/Silk Fabrics for Protective Clothing. ACS Applied Bio Materials. 4(8). 6175–6185. 51 indexed citations

11.

Leung, Preston, Kirston Barton, Martin A. Smith, et al.. (2021). Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants. BMC Genomics. 22(1). 148–148. 20 indexed citations

12.

Kim, Ki Wook, Ira W. Deveson, Chi Nam Ignatius Pang, et al.. (2021). Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Scientific Reports. 11(1). 3934–3934. 50 indexed citations

13.

Kim, Ki Wook, Chi Nam Ignatius Pang, Komal Jain, et al.. (2019). Higher abundance of enterovirus A species in the gut of children with islet autoimmunity. Scientific Reports. 9(1). 1749–1749. 38 indexed citations

14.

Leung, Preston, Auda A. Eltahla, Rowena A. Bull, et al.. (2019). Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing. Infection Genetics and Evolution. 71. 36–41. 15 indexed citations

15.

Isaacs, Sonia R., Ki Wook Kim, Rowena A. Bull, et al.. (2018). Amplification and next generation sequencing of near full-length human enteroviruses for identification and characterisation from clinical samples. Scientific Reports. 8(1). 11889–11889. 22 indexed citations

16.

Rodrigo, Chaturaka, Preston Leung, Andrew R. Lloyd, et al.. (2018). Genomic variability of within‐host hepatitis C variants in acute infection. Journal of Viral Hepatitis. 26(4). 476–484. 7 indexed citations

17.

Eltahla, Auda A., Preston Leung, Chaturaka Rodrigo, et al.. (2017). Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment. Scientific Reports. 7(1). 41719–41719. 14 indexed citations

18.

Bull, Rowena A., Sam Cushman, Richard D. Mace, et al.. (2011). Why replication is important in landscape genetics: American black bear in the Rocky Mountains. Molecular Ecology. 20(6). 1092–1107. 165 indexed citations

19.

Bull, Rowena A., John‐Sebastian Eden, William D . Rawlinson, & Peter A. White. (2010). Correction: Rapid Evolution of Pandemic Noroviruses of the GII.4 Lineage. PLoS Pathogens. 6(4). 31 indexed citations

20.

Bull, Rowena A., et al.. (1983). Riboflavin deficiency in Madang infants.. PubMed. 26(1). 17–20. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact